Genetic etiologies for phenotypic diversity in sickle cell anemia

TheScientificWorldJournal

Volumn 9, Issue , 2009, Pages 46-67

  Steinberg, Martin H ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alpha thalassemia; Fetal hemoglobin; Genotype; SNPs

Indexed keywords

BETA GLOBIN; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; ENDOTHELIN 1; GAMMA GLOBIN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GUANOSINE TRIPHOSPHATE; HEMOGLOBIN F; PROTEIN SAR1A; TRANSCRIPTION FACTOR GATA 1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ACUTE CHEST SYNDROME; ALPHA THALASSEMIA; BACTEREMIA; BONE NECROSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; GALLSTONE; GENE CLUSTER; GENE DELETION; GENE EXPRESSION; GENE LOCUS; GENE SILENCING; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HAPLOTYPE; HUMAN; HYPERBILIRUBINEMIA; KIDNEY DISEASE; LEG ULCER; PRIAPISM; PROGNOSIS; PULMONARY HYPERTENSION; QUANTITATIVE TRAIT LOCUS; REGULATOR GENE; REVIEW; RISK ASSESSMENT; SICKLE CELL ANEMIA; SINGLE NUCLEOTIDE POLYMORPHISM; STROKE; ANIMAL; BLOOD; CLASSIFICATION; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; METABOLISM; PATHOPHYSIOLOGY; PHENOTYPE;

ALPHA-THALASSEMIA; ANEMIA, SICKLE CELL; ANIMALS; FETAL HEMOGLOBIN; GENOTYPE; HUMANS; PHENOTYPE; POLYMORPHISM, GENETIC;

EID: 65549111723     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2009.10     Document Type: Review

References (121)

1. Sebastiani, P., Nolan, V.G., Baldwin, C.T., Abad-Grau, M., Wang, L., Adewoye, A.H., McMahon, L., Farrer, L.A., Taylor, J.G., Kato, G.J., et al. (2007) Predicting severity of sickle cell disease. Blood 110, 2727-2735.
2. Sebastiani, P., Ramoni, M.F., Nolan, V., Baldwin, C.T., and Steinberg, M.H. (2005) Genetic dissection and prognostic modeling of overt stroke in sickle cell anemia. Nat. Genet. 37, 435-440. (Pubitemid 40490496)
3. Kimchi-Sarfaty, C., Oh, J.M., Kim, I.W., Sauna, Z.E., Calcagno, A.M., Ambudkar, S.V., and Gottesman, M.M. (2007) A "silent" polymorphism in the MDR1 gene changes substrate specificity. Science 315, 525-528. (Pubitemid 46175758)
4. Saxena, R., Voight, B.F., Lyssenko, V., Burtt, N.P., de Bakker, P.I., Chen, H., Roix, J.J., Kathiresan, S., Hirschhorn, J.N., Daly, M.J., et al. (2007) Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316, 1331-1336. (Pubitemid 46871653)
5. Balding, D.J. (2006) A tutorial on statistical methods for population association studies. Nat. Rev. Genet. 7, 781-791. (Pubitemid 44413222)
6. Orkin, S.H., Antonarakis, S.E., and Kazazian, H.H., Jr. (1983) Polymorphism and molecular pathology of the human beta-globin gene. Prog. Hematol. 13, 49-73.
7. Antonarakis, S.E., Kazazian, H.H., Jr., and Orkin, S.H. (1985) DNA polymorphism and molecular pathology of the human globin gene clusters. Hum. Genet. 69, 1-14. (Pubitemid 15153905)
8. Nagel, R.L. (1994) Origins and dispersion of the sickle gene. In Sickle Cell Disease: Basic Principles and Clinical Practice. Embury, S.H., Hebbel, R.P., Mohandas, N., and Steinberg, M.H., Eds. Raven Press, New York. pp. 353-380.
9. Bank, A. (2006) Regulation of human fetal hemoglobin: new players, new complexities. Blood 107, 435-443. (Pubitemid 43076362)
10. Pissard, S. and Beuzard, Y. (1994) A potential regulatory region for the expression of fetal hemoglobin in sickle cell disease. Blood 84, 331-338. (Pubitemid 24193839)
11. Nagel, R.L., Fabry, M.E., Pagnier, J., Zohoun, I., Wajcman, H., Baudin, V., and Labie, D. (1984) Hematologically and genetically distinct forms of sickle cell anemia in Africa. The Senegal type and the Benin type. N. Engl. J. Med. 312, 880-884. (Pubitemid 15105672)
12. S gene: origins, epidemiology, and epistasis. In Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management. Steinberg, M.H., Forget, B.G., Higgs, D.R., and Nagel, R.L., Eds. Cambridge University Press, Cambridge. pp. 711-755.
13. s-Gene-cluster haplotypes in sickle cell anemia: clinical and hematologic features. Hematol. Oncol. Clin. North Am. 5, 475-493.
14. s-gene-cluster haplotypes as prognostic indicators of vital organ failure. Semin. Hematol. 28, 202-208.
15. Steinberg, M.H., Hsu, H., Nagel, R.L., Milner, P.F., Adams, J.G., Benjamin, L., Fryd, S., Gillette, P., Gilman, J., Josifovska, O., et al. (1995) Gender and haplotype effects upon hematological manifestations of adult sickle cell anemia. Am. J. Hematol. 48, 175-181.
16. Padmos, M.A., Roberts, G.T., Sackey, K., Kulozik, A., Bail, S., Morris, J.S., Serjeant, B.E., and Serjeant, G.R. (1991) Two different forms of homozygous sickle cell disease occur in Saudi Arabia. Br. J. Haematol. 79, 93-98.
17. El-Hazmi, M.A.F. (1992) Clinical and haematological diversity of sickle cell disease in Saudi children. J. Trop. Pediatr. 38, 106-112.
18. El-Hazmi, M.A.F. (1992) Heterogeneity and variation of clinical and haematological expression of haemoglobin S in Saudi Arabs. Acta Haematol. 88, 67-71. (Pubitemid 23002586)
19. s haplotype and α-globin gene patterns among sickle cell anemia patients in Kuwait. Acta Haematol. 96, 150-154.
20. El-Hazmi, M.A.F., Bahakim, H.M., and Warsy, A.S. (1992) DNA polymorphism in the beta-globin gene cluster in Saudi Arabs: relation to severity of sickle cell anaemia. Acta Haematol. 88, 61-66. (Pubitemid 23002585)
21. Powars, D.R., Elliott Mills, D.D., and Chan, L. (1991) Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality. Ann. Intern. Med. 115, 614-620.
22. Ofori-Acquah, S.F., Lalloz, M.R.A., and Layton, D.M. (1999) Localisation of cis regulatory elements at the β-globin locus: analysis of hybrid haplotype chromosomes. Biochem. Biophys. Res. Commun. 254, 181-187. (Pubitemid 29292037)
23. Ofori-Acquah, S.F., Lalloz, M.R.A., Layton, D.M., and Luzzatto, L. (1996) Localization of CIS-active determinants of fetal hemoglobin level in sickle cell anemia. Blood 88, 493a.
24. Lu, Z.H. and Steinberg, M.H. (1996) Fetal hemoglobin in sickle cell anemia: relation to regulatory sequences cis to the β-globin gene. Blood 87, 1604-1611. (Pubitemid 26056928)
25. Merghoub, T., Maier-Redelsperger, M., Labie, D., Feingold, N., Dibenedetto, S.P., Samperi, P., Schiliro, G., Ducrocq, R., Elion, J., and Krishnamoorthy, R. (1996) Variation of fetal hemoglobin and F-cell number with the LCR-HS2 polymorphism in nonanemic individuals. Blood 87, 2607-2609. (Pubitemid 26086911)
26. Merghoub, T., Perichon, B., Maier-Redelsperger, M., Dibenedetto, S.P., Samperi, P., Ducrocq, R., Feingold, N., Elion, J., Schiliro, G., Labie, D., et al. (1997) Dissection of the association status of two polymorphisms in the β-globin gene cluster with variations in F-cell number in non-anemic individuals. Am. J. Hematol. 56, 239-243. (Pubitemid 127471675)
27. Ofori-Acquah, S.F., Lalloz, M.R., and Layton, D.M. (2001) Nucleotide variation regulates the level of enhancement by hypersensitive site 2 of the beta-globin locus control region. Blood Cells Mol. Dis. 27, 803-811. (Pubitemid 33145025)
28. Ofori-Acquah, S.F., Lalloz, M.R., Serjeant, G., and Layton, D.M. (2004) Dominant influence of gamma-globin promoter polymorphisms on fetal haemoglobin expression in sickle cell disease. Cell Mol. Biol. 50, 35-42.
29. Chen, Z., Hong-Yuan, L., Basran, R.K., Rosenfield, C.G., Patrinos, G.P., Hardison, R., Steinberg, M.H., and Chui, D.H.K. (2008) A T-G transversion at NT-567 upstream of HBG2 in a GATA-1 binding motif is associated with elevated HbF. Mol. Cell. Biol. 28, 4386-4393 (Pubitemid 351904960)
30. Aγ-globin gene expression during adult definitive erythropoiesis mediated by GATA-1-FOG-1-Mi2 complex binding at the -566 GATA site. Mol. Cell. Biol. 28, 3101-3113.
31. Steinberg, M.H., Lu, Z.H., Nagel, R.L., Venkataramani, S., Milner, P.F., Huey, L., Safaya, S., and Rieder, R.F. (1998) Hematological effects of atypical and Cameroon beta-globin gene haplotypes in adult sickle cell anemia. Am. J. Hematol. 59, 121-126. (Pubitemid 28443238)
32. Elion, J., Berg, P.E., Lapouméroulie, C., Trabuchet, G., Mittelman, M., Krishnamoorthy, R., Schechter, A.N., and Labie, D. (1992) DNA sequence variation in a negative control region 5′ to the beta-globin gene correlates with the phenotypic expression of the beta s mutation. Blood 79, 787-792.
33. Mpollo, M.S., Beaudoin, M., Berg, P.E., Beauchemin, H., D'Agati, V., and Trudel, M. (2006) BP1 is a negative modulator of definitive erythropoiesis. Nucleic Acids Res. 34, 5232-5237. (Pubitemid 44742487)
34. Chang, Y.P.C., Maier-Redelsperger, M., Smith, K.D., Contu, L., Ducrocq, R., De Montalembert, M., Belloy, M., Elion, J., Dover, G.J., and Girot, R. (1997) The relative importance of the X-linked FCP locus and β-globin haplotypes in determining haemoglobin F levels: a study of SS patients homozygous for βS haplotypes. Br. J. Haematol. 96, 806-814. (Pubitemid 27115878)
35. Garner, C., Mitchell, J., Hatzis, T., Reittie, J., Farrall, M., and Thein, S.L. (1998) Haplotype mapping of a major quantitative-trait locus for fetal hemoglobin production, on chromosome 6q23. Am. J. Hum. Genet. 62, 1468-1474. (Pubitemid 28307117)
36. Garner, C.P., Tatu, T., Best, S., Creary, L., and Thein, S.L. (2002) Evidence of genetic interaction between the beta-globin complex and chromosome 8q in the expression of fetal hemoglobin. Am. J. Hum. Genet. 70, 793-799. (Pubitemid 34177935)
37. Thein, S.L., Sampietro, M., Rohde, K., Rochette, J., Weatherall, D.J., Lathrop, G.M., and Demenais, F. (1994) Detection of a major gene for heterocellular hereditary persistence of fetal hemoglobin after accounting for genetic modifiers. Am. J. Hum. Genet. 54, 214-228. (Pubitemid 24046333)
38. Garner, C., Silver, N., Best, S., Menzel, S., Martin, C., Spector, T.D., and Thein, S.L. (2004) A quantitative trait locus on chromosome 8q Influences the switch from fetal to adult hemoglobin. Blood 104, 2184-2186. (Pubitemid 39297877)
39. Menzel, S., Garner, C., Gut, I., Matsuda, F., Yamaguchi, M., Heath, S., Foglio, M., Zelenika, D., Boland, A., Rooks, H., et al. (2007) A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15. Nat. Genet. 39, 1197-1199. (Pubitemid 47482679)
40. Uda, M., Galanello, R., Sanna, S., Lettre, G., Sankaran, V.G., Chen, W., Usala, G., Busonero, F., Maschio, A., Albai, G., et al. (2008) Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia. Proc. Natl. Acad. Sci. U. S. A. 105, 1620-1625. (Pubitemid 351346564)
41. Sedgewick, A., Timofeev, N., Sebastiani, P., So, J.C.C., Ma, E.S.K., Chan, L.C., Fuchareon, G., Fuchareon, S., Barbosa, C.G., Baldwin, C.T., et al. (2008) BCL11A (2p16) is a major HbF quantitative trait locus in three different populations. Blood Cells Mol. Dis. 41, 255.
42. Close, J., Game, L., Clark, B., Bergounioux, J., Gerovassili, A., and Thein, S.L. (2004) Genome annotation of a 1.5 Mb region of human chromosome 6q23 encompassing a quantitative trait locus for fetal hemoglobin expression in adults. BMC Genomics 5, 33. (Pubitemid 39546675)
43. Jiang, J., Best, S., Menzel, S., Silver, N., Lai, M.I., Surdulescu, G.L., Spector, T.D., and Thein, S.L. (2006) cMYB is involved in the regulation of fetal hemoglobin production in adults. Blood 108, 1077-1083. (Pubitemid 44154648)
44. Thein, S.L., Menzel, S., Peng, X., Best, S., Jiang, J., Close, J., Silver, N., Gerovasilli, A., Ping, C., Yamaguchi, M., et al. (2007) Intergenic variants of HBS1L-MYB are responsible for a major quantitative trait locus on chromosome 6q23 influencing fetal hemoglobin levels in adults. Proc. Natl. Acad. Sci. U. S. A. 104, 11346-11351. (Pubitemid 47175143)
45. Garner, C., Menzel, S., Martin, C., Silver, N., Best, S., Spector, T.D., and Thein, S.L. (2005) Interaction between two quantitative trait loci affects fetal haemoglobin expression. Ann. Hum. Genet. 69, 707-714. (Pubitemid 41556324)
46. Wyszynski, D.F., Baldwin, C.T., Cleves, M.A., Amirault, Y., Nolan, V.G., Farrell, J.J., Bisbee, A., Kutlar, A., Farrer, L.A., and Steinberg, M.H. (2004) Polymorphisms near a chromosome 6q QTL area are associated with modulation of fetal hemoglobin levels in sickle cell anemia. Cell. Mol. Biol. 50, 23-33.
47. Sebastiani, P., Wang, L., Nolan, V.G., Melista, E., Ma, Q., Baldwin, C.T., and Steinberg, M.H. (2008) Fetal hemoglobin in sickle cell anemia: Bayesian modeling of genetic associations. Am. J. Hematol. 83, 189-195. (Pubitemid 351303941)
48. Ma, Q., Wyszynski, D.F., Farrell, J.J., Kutlar, A., Farrer, L.A., Baldwin, C.T., and Steinberg, M.H. (2007) Fetal hemoglobin in sickle cell anemia: genetic determinants of response to hydroxyurea. Pharmacogenomics J. 7, 386-394. (Pubitemid 350187450)
49. Tang, D.C., Zhu, J., Liu, W., Chin, K., Sun, J., Chen, L., Hanover, J.A., and Rodgers, G.P. (2005) The hydroxyurea-induced small GTP-binding protein SAR modulates γ-globin gene expression in human erythroid cells. Blood 106, 3256-3263. (Pubitemid 41565927)
50. Kumkhaek, C., Taylor, J.G., Zhu, J., Hoppe, C., Kato, G.J., and Rodgers, G.P. (2008) Fetal haemoglobin response to hydroxycarbamide treatment and SAR1A promoter polymorphisms in sickle cell anaemia. Br. J. Haematol. 141, 254-259.
51. Chen, Z., Luo, H.-Y., Tucker, P.W., Steinberg, M.H., and Chui, D.H.K. (2009) BCL11A represses HBG transcription in K562 cells. Blood Cells Mol. Dis., in press.
52. Sankaran, V.G., Menne, T.F., Xu, J., Akie, T.E., Lettre, G., Van, H.B., Mikkola, H.K., Hirschhorn, J.N., Cantor, A.B., and Orkin, S.H. (2008) Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A. Science 322(5909), 1839-1842.
53. Wahlberg, K., Jiang, J., Rooks, H., Best, S., and Thein, S.L. (2008) Functional characterisation of a MYB-HBS1L intergenic region controlling fetal hemoglobin levels in adults. Blood 112, 488a.
54. Steinberg, M.H. and Embury, S.H. (1986) Alpha-thalassemia in blacks: genetic and clinical aspects and interactions with the sickle hemoglobin gene. Blood 68, 985-990. (Pubitemid 17186370)
55. Thomas, P.W., Higgs, D.R., and Serjeant, G.R. (1997) Benign clinical course in homozygous sickle cell disease: a search for predictors. J. Clin. Epidemiol. 50, 121-126. (Pubitemid 27129712)
56. Rother, R.P., Bell, L., Hillmen, P., and Gladwin, M.T. (2005) The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA 293, 1653-1662. (Pubitemid 40471796)
57. Kato, G.J., Gladwin, M.T., and Steinberg, M.H. (2007) Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev. 21, 37-47. (Pubitemid 46110926)
58. Taylor, J.G., Nolan, V.G., Mendelsohn, L., Kato, G.J., Gladwin, M.T., and Steinberg, M.H. (2008) Chronic hyperhemolysis in sickle cell anemia: association of vascular complications and mortality with infrequent vasoocclusive pain. PLoS ONE 3, e2095.
59. Adams, R.J., Kutlar, A., McKie, V., Carl, E., Nichols, F.T., Liu, J.C., McKie, K., and Clary, A. (1994) Alpha thalassemia and stroke risk in sickle cell anemia. Am. J. Hematol. 45, 279-282. (Pubitemid 24109901)
60. Steinberg, M.H., Rosenstock, W., Coleman, M.B., Adams, J.G., III, Platica, O., Cedeno, M., Rieder, R.F., Wilson, J.T., Milner, P., and West, S. (1984) Effects of thalassemia and microcytosis upon the hematological and vasoocclusive severity of sickle cell anemia. Blood 63, 1353-1360. (Pubitemid 14120380)
61. Platt, O.S., Thorington, B.D., Brambilla, D.J., Milner, P.F., Rosse, W.F., Vichinsky, E., and Kinney, T.R. (1991) Pain in sickle cell disease-rates and risk factors. N. Engl. J. Med. 325, 11-16.
62. Milner, P.F., Kraus, A.P., Sebes, J.I., Sleeper, L.A., Dukes, K.A., Embury, S.H., Bellevue, R., Koshy, M., Moohr, J.W., and Smith, J. (1993) Osteonecrosis of the humeral head in sickle cell disease. Clin. Orthop. 289, 136-143. (Pubitemid 23124801)
63. Nolan, V.G., Wyszynski, D.F., Farrer, L.A., and Steinberg, M.H. (2005) Hemolysis-associated priapism in sickle cell disease. Blood 106, 3264-3267. (Pubitemid 41565928)
64. Nolan, V.G., Adewoye, A., Baldwin, C., Wang, L., Ma, Q., Wyszynski, D.F., Farrell, J.J., Sebastiani, P., Farrer, L.A., and Steinberg, M.H. (2006) Sickle cell leg ulcers: associations with haemolysis and SNPs in Klotho, TEK and genes of the TGF-beta/BMP pathway. Br. J. Haematol. 133, 570-578.
65. Hsu, L.L., Miller, S.T., Wright, E., Kutlar, A., McKie, V., Wang, W., Pegelow, C.H., Driscoll, C., Hurlet, A., Woods, G., et al. (2003) Alpha Thalassemia is associated with decreased risk of abnormal transcranial Doppler ultrasonography in children with sickle cell anemia. J. Pediatr. Hematol. Oncol. 25, 622-628. (Pubitemid 36959423)
66. Bernaudin, F., Verlhac, S., Chevret, S., Torres, M., Coic, L., Arnaud, C., Kamdem, A., Hau, I., Neonato, M.G., and Delacourt, C. (2008) G6PD deficiency, absence of αand hemolytic rate at baseline are significant independent risk factors for abnormally high cerebral velocities in patients with sickle cell anemia. Blood 112, 4314-4317.
67. Alexander, N., Higgs, D., Dover, G., and Serjeant, G.R. (2004) Are there clinical phenotypes of homozygous sickle cell disease? Br. J. Haematol. 126, 606-611. (Pubitemid 39093105)
68. Steinberg, M.H. (2005) Predicting clinical severity in sickle cell anaemia. Br. J. Haematol. 129, 465-481. (Pubitemid 40769896)
69. Bertolino, P., Deckers, M., Lebrin, F., and ten Dikje, P. (2005) Transforming growth factor-beta signal transduction in angiogenesis and vascular disorders. Chest 128, 585S-590S.
70. Shapiro, B.S. and Ballas, S.K. (1994) The acute painful episode. In Sickle Cell Disease: Basic Principles and Clinical Practice. Embury, S.H., Hebbel, R.P., Mohandas, N., and Steinberg, M.H., Eds. Raven Press, New York. pp. 531-543.
71. Platt, O.S., Brambilla, D.J., Rosse, W.F., Milner, P.F., Castro, O., Steinberg, M.H., and Klug, P.P. (1994) Mortality in sickle cell disease. Life expectancy and risk factors for early death. N. Engl. J. Med. 330, 1639-1644. (Pubitemid 124005049)
72. Lotsch, J., Skarke, C., Liefhold, J., and Geisslinger, G. (2004) Genetic predictors of the clinical response to opioid analgesics: clinical utility and future perspectives. Clin. Pharmacokinet. 43, 983-1013. (Pubitemid 39602014)
73. Driscoll, M.C., Hurlet, A., Styles, L., McKie, V., Files, B., Olivieri, N., Pegelow, C., Berman, B., Drachtman, R., Patel, K., et al. (2003) Stroke risk in siblings with sickle cell anemia. Blood 101, 2401-2404. (Pubitemid 36302088)
74. Taylor, J.G., Tang, D.C., Savage, S.A., Leitman, S.F., Heller, S.I., Serjeant, G.R., Rodgers, G.P., and Chanock, S.J. (2002) Variants in the VCAM1 gene and risk for symptomatic stroke in sickle cell disease. Blood 100, 4303-4309. (Pubitemid 35429667)
75. Hoppe, C., Klitz, W., Cheng, S., Apple, R., Steiner, L., Robles, L., Girard, T., Vichinsky, E., and Styles, L. (2004) Gene interactions and stroke risk in children with sickle cell anemia. Blood 103, 2391-2396. (Pubitemid 38326263)
76. Kutlar, A., Brambilla, D., Clair, B., Haghighat, A., Bakanay, S.M., Adams, G., Kutlar, F., McKie, V., Files, B., Woods, G., et al. (2007) Candidate gene polymorphisms and their association with TCD velocities in children with sickle cell disease. Blood 110, 133a.
77. Styles, L.A., Hoppe, C., Klitz, W., Vichinsky, E., Lubin, B., and Trachtenberg, E. (2000) Evidence for HLA-related susceptibility for stroke in children with sickle cell disease. Blood 95, 3562-3567. (Pubitemid 30428492)
78. Hoppe, C., Klitz, W., Noble, J., Vigil, L., Vichinsky, E., and Styles, L. (2002) Distinct HLA associations by stroke subtype in children with sickle cell anemia. Blood 101, 2865-2869.
79. Tang, D.C., Prauner, R., Liu, W., Kim, K.H., Hirsch, R.P., Driscoll, M.C., and Rodgers, G.P. (2001) Polymorphisms within the angiotensinogen gene (GT-repeat) and the risk of stroke in pediatric patients with sickle cell disease: a case-control study. Am. J. Hematol. 68, 164-169. (Pubitemid 32983204)
80. Romana, M., Diara, J.P., Doumbo, L., Muralitharan, S., Ramasawmy, R., Keclard, L., Tarer, V., Chaar, V., Elion, J., Krishnamoorthy, R., et al. (2004) Angiotensinogen gene associated polymorphisms and risk of stroke in sickle cell anemia: additional data supporting an association. Am. J. Hematol. 76, 310-311. (Pubitemid 38828861)
81. Hoppe, C., Cheng, S., Grow, M., Silbergleit, A., Klitz, W., Trachtenberg, E., Erlich, H., Vichinsky, E., and Styles, L. (2001) A novel multilocus genotyping assay to identify genetic predictors of stroke in sickle cell anaemia. Br. J. Haematol. 114, 718-720. (Pubitemid 32953657)
82. Romana, M., Muralitharan, S., Ramasawmy, R., Nagel, R.L., and Krishnamoorthy, R. (2002) Thrombosis-associated gene variants in sickle cell anemia. Thromb. Haemost. 87, 356-358. (Pubitemid 34139887)
83. Milbauer, L.C., Wei, P., Enenstein, J., Jiang, A., Hillery, C.A., Scott, J.P., Nelson, S.C., Bodempudi, V., Topper, J.N., Yang, R.B., et al. (2008) Genetic endothelial systems biology of sickle stroke risk. Blood 111, 3872-3879.
84. Nolan, V.G., Baldwin, C.T., Ma, Q.-L., Wyszynski, D.F., Amirault, Y., Farrell, J.J., Bisbee, A., Embury, S.H., Farrer, L.A., and Steinberg, M.H. (2004) Association of single nucleotide polymorphisms in KLOTHO with priapism in sickle cell anemia. Br. J. Haematol. 128, 266-272.
85. Elliott, L., Ashley-Koch, A., Castro, L.D., Jonassaint, J., Price, J., Ataga, K., Levesque, M.C., Wienberg, B.J., Eckman, J.R., Orringer, E.P., et al. (2007) Genetic polymorphisms associated with priapism in sickle cell disease. Br. J. Haematol. 137, 262-267. (Pubitemid 46537636)
86. El-Khatib, A., Ashley-Koch, A., Kail, M., Collins, A., Jonassaint, J., Adam, S.S., Ataga, K., Eckmam, J.R., Orringer, E.P., Greenberg, C.S., et al. (2007) Further investigation of the role of factor XIII in priapism associated with SCD. Blood 110, 998a.
87. Kutlar, F., Tural, C., Park, D., Markowitz, R.B., Woods, K.F., and Kutlar, A. (1998) MTHFR (5, 10- methlylenetetrathydrofolate reductase) 677 C->T mutation as a candidate risk factor for avascular necrosis (AVN) in patients with sickle cell disease. Blood 92, 695a.
88. Zimmerman, S.A. and Ware, R.E. (1998) Inherited DNA mutations contributing to thrombotic complications in patients with sickle cell disease. Am. J. Hematol. 59, 267-272. (Pubitemid 28543614)
89. Baldwin, C., Nolan, V.G., Wyszynski, D.F., Ma, Q.L., Sebastiani, P., Embury, S.H., Bisbee, A., Farrell, J., Farrer, L., and Steinberg, M.H. (2005) Association of klotho, bone morphogenic protein 6, and annexin A2 polymorphisms with sickle cell osteonecrosis. Blood 106, 372-375. (Pubitemid 40967216)
90. Adewoye, A.H., Nolan, V.G., Ma, Q., Baldwin, C., Wyszynski, D.F., Farrell, J.J., Farrer, L.A., and Steinberg, M.H. (2006) Association of polymorphisms of IGF1R and genes in the transforming growth factor-beta /bone morphogenetic protein pathway with bacteremia in sickle cell anemia. Clin. Infect. Dis. 43, 593-598. (Pubitemid 44267118)
91. Tamouza, R., Neonato, M.G., Busson, M., Marzais, F., Girot, R., Labie, D., Elion, J., and Charron, D. (2002) Infectious complications in sickle cell disease are influenced by HLA class II alleles. Hum. Immunol. 63, 194-199. (Pubitemid 34246052)
92. Neonato, M.G., Lu, C.Y., Guilloud-Bataille, M., Lapouméroulie, C., Nabeel-Jassim, H., Dabit, D., Girot, R., Krishnamoorthy, R., Feingold, J., Besmond, C., et al. (1999) Genetic polymorphism of the mannose-binding protein gene in children with sickle cell disease: identification of three new variant alleles and relationship to infections. Eur. J. Hum. Genet. 7, 679-686. (Pubitemid 29424059)
93. Norris, C.F., Surrey, S., Bunin, G.R., Schwartz, E., Buchanan, G.R., and McKenzie, S.E. (1996) Relationship between Fc receptor IIA polymorphism and infection in children with sickle cell disease. J. Pediatr. 128, 813-819. (Pubitemid 26181379)
94. Powars, D.R., Chan, L., and Schroeder, W.A. (1990) Beta S-gene-cluster haplotypes in sickle cell anemia: clinical implications. Am. J. Pediatr. Hematol. Oncol. 12, 367-374. (Pubitemid 20323441)
95. Nolan, V.G., Ma, Q., Cohen, H.T., Adewoye, A.H., Rybicki, A.C., Baldwin, C.T., Wyszynski, D.F., Wang, L.C., Sebastiani, P., Fabry, M., et al. (2007) Estimated glomerular filtration rate in sickle cell anemia is associated with polymorphisms of bone morphogenetic protein receptor 1B. Am. J. Hematol. 82, 179-184. (Pubitemid 46363782)
96. Gladwin, M.T., Sachdev, V., Jison, M.L., Shizukuda, Y., Plehn, J.F., Minter, K., Brown, B., Coles, W.A., Nichols, J.S., Ernst, I., et al. (2004) Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N. Engl. J. Med. 350, 886-895. (Pubitemid 38252536)
97. Ameshima, S., Golpon, H., Cool, C.D., Chan, D., Vandivier, R.W., Gardai, S.J., Wick, M., Nemenoff, R.A., Geraci, M.W., and Voelkel, N.F. (2003) Peroxisome proliferator-activated receptor gamma (PPARgamma) expression is decreased in pulmonary hypertension and affects endothelial cell growth. Circ. Res. 92, 1162-1169. (Pubitemid 36665863)
98. Nichols, W.C., Koller, D.L., Slovis, B., Foroud, T., Terry, V.H., Arnold, N.D., Siemieniak, D.R., Wheeler, L., Phillips, J.A., III, Newman, J.H., et al. (1997) Localization of the gene for familial primary pulmonary hypertension to chromosome 2q31-32. Nat. Genet. 15, 277-280. (Pubitemid 27098722)
99. Machado, R.D., Pauciulo, M.W., Thomson, J.R., Lane, K.B., Morgan, N.V., Wheeler, L., Phillips, J.A., III, Newman, J., Williams, D., Galie, N., et al. (2001) BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension. Am. J. Hum. Genet. 68, 92-102. (Pubitemid 32048364)
100. Ashley-Koch, A.E., Elliott, L., Kail, M.E., De Castro, L.M., Jonassaint, J., Jackson, T.L., Price, J., Ataga, K.I., Levesque, M.C., Weinberg, J.B., et al. (2008) Identification of genetic polymorphisms associated with risk for pulmonary hypertension in sickle cell disease. Blood 111, 5721-5726.
101. Vichinsky, E.P., Neumayr, L.D., Earles, A.N., Williams, R., Lennette, E.T., Dean, D., Nickerson, B., Orringer, E., McKie, V., Bellevue, R., et al. (2000) Causes and outcomes of the acute chest syndrome in sickle cell disease. N. Engl. J. Med. 342, 1855-1865. (Pubitemid 30419049)
102. Sharan, K., Surrey, S., Ballas, S., Borowski, M., Devoto, M., Wang, K.F., Sandler, E., and Keller, M. (2004) Association of T-786C eNOS gene polymorphism with increased susceptibility to acute chest syndrome in females with sickle cell disease. Br. J. Haematol. 124, 240-243. (Pubitemid 38122198)
103. Chaar, V., Tarer, V., Etienne-Julan, M., Diara, J.P., Elion, J., and Romana, M. (2006) ET-1 and eNOS gene polymorphisms and susceptibility to acute chest syndrome and painful vaso-occlusive crises in children with sickle cell anemia. Haematologica 91, 1277-1278. (Pubitemid 44408445)
104. Duckworth, L., Hsu, L., Feng, H., Wang, J., Sylvester, J.E., Kissoon, N., Sandler, E., and Lima, J.J. (2007) Physician-diagnosed asthma and acute chest syndrome: associations with NOS polymorphisms. Pediatr. Pulmonol. 42, 332-338. (Pubitemid 46608902)
105. Sullivan, K.J., Kissoon, N., Duckworth, L.J., Sandler, E., Freeman, B., Bayne, E., Sylvester, J.E., and Lima, J.J. (2001) Low exhaled nitric oxide and a polymorphism in the NOS I gene is associated with acute chest syndrome. Am. J. Respir. Crit. Care Med. 164, 2186-2190. (Pubitemid 34032933)
106. Martinez-Castaldi, C., Nolan, V.G., Baldwin, C.T., Farrer, L.A., Steinberg, M.H., and Klings, E.S. (2007) Association of genetic polymorphisms in the TGF-β pathway with the acute chest syndrome of sickle cell disease. Blood 110, 666a.
107. Fertrin, K.Y., Melo, M.B., Assis, A.M., Saad, S.T., and Costa, F.F. (2003) UDP-glucuronosyltransferase 1 gene promoter polymorphism is associated with increased serum bilirubin levels and cholecystectomy in patients with sickle cell anemia. Clin. Genet. 64, 160-162. (Pubitemid 36944110)
108. Passon, R.G., Howard, T.A., Zimmerman, S.A., Schultz, W.H., and Ware, R.E. (2001) Influence of bilirubin uridine diphosphate-glucuronosyltransferase 1A promoter polymorphisms on serum bilirubin levels and cholelithiasis in children with sickle cell anemia. J. Pediatr. Hematol. Oncol. 23, 448-451. (Pubitemid 33031774)
109. Adekile, A., Kutlar, F., McKie, K., Addington, A., Elam, D., Holley, L., Clair, B., and Kutlar, A. (2005) The influence of uridine diphosphate glucuronosyl transferase 1A promoter polymorphisms, beta-globin gene haplotype, co-inherited alpha-thalassemia trait and Hb F on steady-state serum bilirubin levels in sickle cell anemia. Eur. J. Haematol. 75, 150-155. (Pubitemid 41008286)
110. Vasavda, N., Menzel, S., Kondaveeti, S., Maytham, E., Awogbade, M., Bannister, S., Cunningham, J., Eichholz, A., Daniel, Y., Okpala, I., et al. (2007) The linear effects of alpha-thalassaemia, the UGT1A1 and HMOX1 polymorphisms on cholelithiasis in sickle cell disease. Br. J. Haematol. 138, 263-270. (Pubitemid 46976326)
111. Haverfield, E.V., McKenzie, C.A., Forrester, T., Bouzekri, N., Harding, R., Serjeant, G., Walker, T., Peto, T.E., Ward, R., and Weatherall, D.J. (2005) UGT1A1 variation and gallstone formation in sickle cell disease. Blood 105, 968-972. (Pubitemid 40170862)
112. Chaar, V., Keclard, L., Etienne-Julan, M., Diara, J.P., Elion, J., Krishnamoorthy, R., and Romana, M. (2006) UGT1A1 polymorphism outweighs the modest effect of deletional (-3.7 kb) alpha-thalassemia on cholelithogenesis in sickle cell anemia. Am. J. Hematol. 81, 377-379.
113. Steinberg, M.H., West, M.S., Gallagher, D., and Mentzer, W. (1988) Effects of glucose-6-phosphate dehydrogenase deficiency upon sickle cell anemia. Blood 71, 748-752. (Pubitemid 18102098)
114. Bouanga, J.C., Mouélé, R., Préhu, C., Wajcman, H., Feingold, J., and Galactéros, F. (1998) Glucose-6-phosphate dehydrogenase deficiency and homozygous sickle cell disease in congo. Hum. Hered. 48, 192-197. (Pubitemid 28362460)
115. Belhassen, L., Pelle, G., Sediame, S., Bachir, D., Carville, C., Bucherer, C., Lacombe, C., Galacteros, F., and Adnot, S. (2001) Endothelial dysfunction in patients with sickle cell disease is related to selective impairment of shear stress-mediated vasodilation. Blood 97, 1584-1589. (Pubitemid 32217221)
116. Forgione, M.A., Loscalzo, J., Holbrook, M., Melduni, R., Scribner, A.W., Palmisano, J., Maxwell, C., Gokce, N., Baldwin, C., and Vita, J. (2003) The A326G (A+) variant of the glucose-6-phosphate dehydrogenase gene is associated with endothelial dysfunction in African Americans. J. Am. Coll. Cardiol. 41, 249a.
117. Leopold, J., Dam, A., Maron, B.A., Scribner, A.W., Liao, R., Handy, D.E., Stanton, R.C., Pitt, B., and Loscalzo, J. (2007) Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity. Nat. Med. 13, 189-197. (Pubitemid 46245770)
118. Castro, V., Alberto, F.L., Costa, R.N., Lepikson-Neto, J., Gualandro, S.F., Figueiredo, M.S., Annichino-Bizzacchi, J.M., Saad, S.T., and Costa, F.F. (2004) Polymorphism of the human platelet antigen-5 system is a risk factor for occlusive vascular complications in patients with sickle cell anemia. Vox Sang. 87, 118-123. (Pubitemid 39265460)
119. Sebastiani, P., Wang, L., Perls, T., Terry, D., Montano, M.A., Baldwin, C.T., and Steinberg, M.H. (2007) A repertoire of genes modifying the risk of death in sickle cell anemia. Blood 110, 52a.
120. Steinberg, M.H. (2008) SNPing away at sickle cell pathophysiology. Blood 111, 5420-5421.
121. Sebastiani, P., Timofeev, N., Hartley, S.H., Dworkis, D., Farrer, L., Baldwin, C.T., Perls, T.T., and Steinberg, M.H. (2008) Genome-wide association studies suggest shared polymorphisms are associated with severity of sickle cell anemia and exceptional longevity. Blood 112, 1446a.